Inflation is raging, with consumer prices soaring 8.3% in the 12 months through April.

Vertex is one step closer to getting its new pain pill approved, which could substitute for opioids that are highly addictive.

Valuations for biotech stocks have slumped. This in particular opens up great opportunities for mergers and acquisitions.

Valuations for biotech stocks have slumped, but could rebound.

Amazon's surprise 20-for-1 stock split, the first in two decades, could help the world's largest retailer tackle one of its biggest challenges.

Scammers are taking advantage of the crypto craze to line their pockets, FTC says.

Sky-high home prices are driving younger buyers out of the market.

The CEO of Tesla has become one of the most influential voices in the world.

Roblox's shares are down 71% since January.